BEST of ASCO Portugal 2024 - Advanced Lung Cancer
In non-small cell lung cancer (NSCLC), therapies directed at molecular targets have been one of the areas with the greatest growth, with numerous trials reporting new results and many others still in progress. At this year's ASCO congress, 4 studies related to the treatment of patients with the ALK rearrangement, the KRAS G12C mutation and the EGFR mutation stood out.
Publication Details
- Journal
- Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
- Published
- 2024-11-26
- Primary Topic
- Magnetic confinement fusion research
- Type
- article
- Field-Weighted Citation Impact
- 0.00